Paclitaxel — Dosing in CKD & Dialysis

Paclitaxel (Antineoplastic): renal dosing adjustments, dialyzability (Negligible (not dialyzable: paclitaxel was undetectable in the dialysate of an anephric patient on hemodialysis; Woo 1999, PMID 9923547; Janus 2010 review)), and renal-relevant safety risk for CKD and dialysis patients. Educationa

Reviewed by Matt · November 16, 2026

NephroResource

Taking longer than expected

If you're on a slow connection or this keeps happening, tap below to reload.